INVO Fertility (IVF) Corporate presentation summary

Mission and market focus

• Aims to make advanced fertility care effective, accessible, and empowering through innovation and a patient-centered approach.

• Expanding from a device-focused company to a comprehensive fertility healthcare provider.

• Targets underserved markets with a combination of proprietary technology and clinic operations.

Financial performance and growth

• Clinic revenue grew from $1.7M in 2022 to $7.7M in 2024, with $6.1M in the first nine months of 2025.

• Adjusted EBITDA loss reduced from -$8.4M in 2022 to -$2.2M in 2024.

• Targeting cash flow breakeven in 2026 and profitability in 2027.

Strategic initiatives and acquisitions

• Pursuing M&A strategy, focusing on acquiring profitable US fertility clinics and related businesses.

• Acquired Wisconsin Fertility Institute, driving significant revenue and EBITDA improvements.

• Signed agreement to acquire Family Beginnings clinic in Indianapolis, with further acquisitions planned.